Search results
Results from the WOW.Com Content Network
Richard Stephen Sackler (born March 10, 1945) [1] is an American businessman and physician who was the chairman and president of Purdue Pharma, a former company best known as the developer of OxyContin, whose role in the opioid epidemic in the United States became the subject of many lawsuits and fines, filing for bankruptcy in 2019.
Former Purdue Pharma executive Richard Sackler eventually distanced himself from the company. In 2003, Richard stepped down as president of the notorious pharmaceutical company.
Netflix’s “Painkiller” recounts the rise of Oxycontin, a highly addictive prescription drug manufactured by Purdue Pharma, and the people behind the drug — including Richard Sackler, the former...
As the nation continues to grapple with the opioid epidemic, the Sackler family had agreed to pay $6 billion to families and states as part of an agreement to wind down Purdue Pharma, the maker...
Where is Richard Sackler Now? After stepping down from the role of President, Sackler remained involved with Purdue Pharma as a board member. In 2015, he was deposed by lawyers in a lawsuit filed by Kentucky State against the company and the Sacklers.
Painkiller, a Netflix drama out Aug. 10, follows the mint green OxyContin pill’s trail of destruction from the very top—Richard Sackler (Matthew Broderick), the former chairman and president of...
The Supreme Court on Thursday blocked Purdue Pharma from going forward with bankruptcy proceedings, which the Biden administration has called an “unprecedented” arrangement that would ultimately...
Dr. Richard Sackler, a former president and co-chairman of Purdue’s board of directors, said that neither the family, the company nor its products bore responsibility for the opioid epidemic.
The ending of Netflix‘s Painkiller puts a lot of energy into properly punishing its antagonist Richard Sackler (Matthew Broderick).
And, six Sacklers sat on the board of the company, including the chairman Richard Sackler, who closely directed the firm's aggressive and deceptive marketing strategy of OxyContin as not...